Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.
Paradigm Biopharmaceuticals Limited has applied for the quotation of new securities on the ASX, with 443,332 ordinary shares to be quoted under the code PAR. The application coincides with the issue date of the shares, which is September 10, 2024. This move signals the company’s progression in the financial markets and provides an opportunity for investors to engage with Paradigm’s growth.
For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.
